The Probiotics in Pediatric Asthma Management (PROPAM) Study in the Primary Care Setting: A Randomized, Controlled, Double-Blind Trial with Ligilactobacillus salivarius LS01 (DSM 22775) and Bifidobacterium breve B632 (DSM 24706)

BACKGROUND: Type-2 inflammation commonly marks asthma in childhood. Also, gut and lung dysbiosis is detectable in patients with asthma. Strain-related probiotic supplementation may restore a physiological immune response, dampen airway inflammation, and repair dysbiosis. Therefore, the probiotics in...

Descripción completa

Detalles Bibliográficos
Autores principales: Drago, Lorenzo, Cioffi, Luigi, Giuliano, Maria, Pane, Marco, Amoruso, Angela, Schiavetti, Irene, Reid, Gregor, Ciprandi, Giorgio, PROPAM Study Group
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786459/
https://www.ncbi.nlm.nih.gov/pubmed/35083341
http://dx.doi.org/10.1155/2022/3837418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786459/
https://www.ncbi.nlm.nih.gov/pubmed/35083341
http://dx.doi.org/10.1155/2022/3837418

Ejemplares similares